Molecular Biology of the Cell click for CBE Life Science Education Page

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

MBC in Press, published online ahead of print February 11, 2009
Mol. Biol. Cell 10.1091/mbc.E08-09-0916

A more recent version of this article appeared on April 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-09-0916v1
20/7/1960    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narbonne-Reveau, K.
Right arrow Articles by Lilly, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narbonne-Reveau, K.
Right arrow Articles by Lilly, M.

Submitted on September 9, 2008
Revised on January 12, 2009
Accepted on January 30, 2009

The Cyclin-dependent Kinase Inhibitor Dacapo Promotes Genomic Stability during Premeiotic S Phase

Karine Narbonne-Reveau and Mary Lilly

Cell Biology and Metabolism Program, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892

Monitoring Editor: Yixian Zheng

The proper execution of premeiotic S phase is essential to both the maintenance of genomic integrity and accurate chromosome segregation during the meiotic divisions. However, the regulation of premeiotic S phase remains poorly defined in metazoa. Here we identify the p21Cip1/p27Kip1/p57Kip2–like Cyclin-dependent kinase inhibitor (CKI) Dacapo (Dap) as a key regulator of premeiotic S phase and genomic stability during Drosophila oogenesis. In dap-/- females, ovarian cysts enter the meiotic cycle with high levels of Cyclin E/Cdk2 activity and accumulate DNA damage during the premeiotic S phase. High Cyclin E/Cdk2 activity inhibits the accumulation of the replication-licensing factor Doubleparked/Cdt1 (Dup/Cdt1). Accordingly, we find that dap-/- ovarian cysts have low levels of Dup/Cdt1. Moreover, mutations in dup/cdt1 dominantly enhance the dap-/- DNA damage phenotype. Importantly, the DNA damage observed in dap-/- ovarian cysts is independent of the DNA double-strands breaks that initiate meiotic recombination. Taken together, our data suggest that the CKI Dap promotes the licensing of DNA replication origins for the premeiotic S phase by restricting Cdk activity in the early meiotic cycle. Finally, we report that dap-/- ovarian cysts frequently undergo an extra mitotic division before meiotic entry, indicating that Dap influences the timing of the mitotic/meiotic transition.

Address correspondence to: Mary Lilly (mlilly{at}helix.nih.gov)






Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Copyright © 2009 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.